Product Information
FONDAPARINUX 10 MG/0.8 ML SYR is a generic product labeled by Eugia US LLC, priced at $44.8161 per ML under NDC 55150023310. Its NADAC has been published 220 times since Jul 20, 2022.
FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/.8mL
Manufacturer
Eugia US LLCNDC
55150023310
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206918FDA Approved
12/26/2017
TE Code
AP
On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has been published 220 times since Jul 20, 2022, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $44.8161 per ML |
|---|---|
| All-time high | $53.5408 (May 15, 2024) |
| All-time low | $29.5253 (May 21, 2025) |
| 52-week high | $46.2815 |
| 52-week low | $31.8179 |
| Median price | $45.0801 |
| Average price | $43.2371 |
| Largest weekly change | -26.6% (May 22, 2024) |
| Weeks tracked | 220 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FONDAPARINUX SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor Xa Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FONDAPARINUX 10 MG/0.8 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 10 MG/0.8 ML SYR, manufactured by Eugia US LLC, is $44.8161 per ML (NDC 55150023310), effective Sep 30, 2026.
How has the price of FONDAPARINUX 10 MG/0.8 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has declined 10.5%. It has been tracked across 220 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 10 MG/0.8 ML SYR?
Since Jul 20, 2022, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has ranged from a low of $29.5253 (May 21, 2025) to a high of $53.5408 (May 15, 2024), with a median of $45.0801 per ML.
Are there cheaper alternatives to FONDAPARINUX 10 MG/0.8 ML SYR?
No other NADAC-published product currently shares the active ingredient and strength of FONDAPARINUX 10 MG/0.8 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FONDAPARINUX 10 MG/0.8 ML SYR?
FONDAPARINUX 10 MG/0.8 ML SYR (NDC 55150023310) is labeled by Eugia US LLC, and CMS classifies it as a generic product.